Topoisomerase IIβ mediates the resistance of glioblastoma stem cells to replication stress-inducing drugs

Saša Kenig, Valentina Faoro, Evgenia Bourkoula, Neža Podergajs, Tamara Ius, Marco Vindigni, Miran Skrap, Tamara Lah, Daniela Cesselli, Paola Storici, Alessandro Vindigni

Research output: Contribution to journalArticle

6 Scopus citations

Abstract

Background: Glioblastoma stem cells (GSC) have been extensively recognized as a plausible cause of glioblastoma resistance to therapy and recurrence resulting in high glioblastoma mortality. Abnormalities in the DNA repair pathways might be responsible for the inability of the currently used chemotherapeutics to eliminate the (GSC) subpopulation. Methods: In this work, we compared the expression of sixty DNA repair related genes between primary glioblastoma cell cultures and the glioblastoma enriched stem cell primary cultures. MTT test was used to analyze the effect of selected drugs and immunofluorescence to evaluate the load of DNA damage. Results: We found several differentially expressed genes and we identified topoisomerase IIβ (Top2β) as the gene with highest up-regulation in GSC. Also among the tested cell lines the expression of Top2β was the highest in NCH421k cells, a well-characterized glioblastoma cell line with all the stemness characteristics. On the other hand, Top2β expression markedly decreased upon the induction of differentiation by all trans-retinoic acid. Depletion of Top2β increased the sensitivity of NCH421k cells to replication stress inducing drugs, such as cisplatin, methyl-methanesulfonate, hydrogen peroxide, and temozolomide. Consistently, we found an increased load of DNA damage and increased Chk1 activation upon Top2β depletion in NCH421k cells. Conclusion: We suggest that Top2β may represent a new target for gene therapy in glioblastoma. In addition, the other genes that we found to be up-regulated in GSC versus glioblastoma primary cells should be further investigated as glioblastoma theranostics.

Original languageEnglish
Article number58
JournalCancer Cell International
Volume16
Issue number1
DOIs
StatePublished - Jul 26 2016
Externally publishedYes

Keywords

  • Drug resistance
  • Glioblastoma stem cells
  • Glioma
  • Replication stress
  • Theranostic markers
  • Topoisomerase IIβ

Fingerprint Dive into the research topics of 'Topoisomerase IIβ mediates the resistance of glioblastoma stem cells to replication stress-inducing drugs'. Together they form a unique fingerprint.

  • Cite this

    Kenig, S., Faoro, V., Bourkoula, E., Podergajs, N., Ius, T., Vindigni, M., Skrap, M., Lah, T., Cesselli, D., Storici, P., & Vindigni, A. (2016). Topoisomerase IIβ mediates the resistance of glioblastoma stem cells to replication stress-inducing drugs. Cancer Cell International, 16(1), [58]. https://doi.org/10.1186/s12935-016-0339-9